{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:31:19Z","timestamp":1769203879432,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","interventional.theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.iccl.2015.12.007","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T12:03:42Z","timestamp":1455537822000},"page":"221-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antiplatelet Therapy in Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"5","author":[{"given":"Alexander C.","family":"Fanaroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iccl.2015.12.007_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00380-012-0276-z","article-title":"Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial","volume":"28","author":"Mrdovic","year":"2013","journal-title":"Heart Vessels"},{"issue":"4","key":"10.1016\/j.iccl.2015.12.007_bib2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH13-02-0092","article-title":"Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation","volume":"110","author":"De Luca","year":"2013","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.iccl.2015.12.007_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCINTERVENTIONS.111.963884","article-title":"Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial","volume":"4","author":"Palmerini","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.iccl.2015.12.007_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2011.02.011","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.iccl.2015.12.007_bib5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.iccl.2015.12.007_bib6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jcin.2012.05.010","article-title":"Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients","volume":"5","author":"Rao","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.iccl.2015.12.007_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jama.2013.1556","article-title":"Association between bleeding events and in-hospital mortality after percutaneous coronary intervention","volume":"309","author":"Chhatriwalla","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.iccl.2015.12.007_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijcard.2012.01.080","article-title":"Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses","volume":"167","author":"D'Ascenzo","year":"2013","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.iccl.2015.12.007_bib9","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.2010.708","article-title":"Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention","volume":"303","author":"Marso","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.iccl.2015.12.007_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.108.842757","article-title":"Early stent thrombosis: past, present, and future","volume":"119","author":"Cook","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.iccl.2015.12.007_bib11","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A\u00a0risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2015.12.007_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4244\/EIJV9I1A10","article-title":"Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting","volume":"9","author":"Iqbal","year":"2013","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.iccl.2015.12.007_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.108.804203","article-title":"Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial","volume":"119","author":"Aoki","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.iccl.2015.12.007_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00626364","article-title":"Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration","volume":"41","author":"Di Perri","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"issue":"18","key":"10.1016\/j.iccl.2015.12.007_bib15","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.CIR.99.18.2364","article-title":"Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation","volume":"99","author":"Moussa","year":"1999","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.iccl.2015.12.007_bib16","first-page":"547","article-title":"The evolution of antiplatelet therapy in cardiovascular disease. Nature reviews","volume":"8","author":"Yousuf","year":"2011","journal-title":"Cardiology"},{"issue":"24","key":"10.1016\/j.iccl.2015.12.007_bib17","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/01.CIR.101.24.2823","article-title":"Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans","volume":"101","author":"Cadroy","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.iccl.2015.12.007_bib18","first-page":"325","article-title":"Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study","volume":"16","author":"Angiolillo","year":"2004","journal-title":"J\u00a0Invasive Cardiol"},{"issue":"15","key":"10.1016\/j.iccl.2015.12.007_bib19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","article-title":"Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties","volume":"73","author":"Ferri","year":"2013","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.iccl.2015.12.007_bib20","doi-asserted-by":"crossref","first-page":"66.e9","DOI":"10.1016\/j.ahj.2006.10.010","article-title":"A\u00a0comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation","volume":"153","author":"Brandt","year":"2007","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.iccl.2015.12.007_bib21","first-page":"626","article-title":"Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease","volume":"100","author":"Braun","year":"2008","journal-title":"Thromb Haemost"},{"issue":"25","key":"10.1016\/j.iccl.2015.12.007_bib22","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.iccl.2015.12.007_bib23","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.iccl.2015.12.007_bib24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.iccl.2015.12.007_bib25","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0002-9149(99)80345-2","article-title":"Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb\/IIIa inhibitor during percutaneous coronary intervention","volume":"76","author":"Harrington","year":"1995","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2015.12.007_bib26","doi-asserted-by":"crossref","first-page":"s38","DOI":"10.1067\/mhj.2000.103742","article-title":"Clinical challenges of platelet glycoprotein IIb\/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment","volume":"139","author":"Tcheng","year":"2000","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.iccl.2015.12.007_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A\u00a0comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.iccl.2015.12.007_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A\u00a0randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease","volume":"331","author":"Fischman","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2015.12.007_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199101033240103","article-title":"Angiographic follow-up after placement of a self-expanding coronary-artery stent","volume":"324","author":"Serruys","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iccl.2015.12.007_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.93.3.412","article-title":"Heparin-coated Palmaz-Schatz stents in human coronary arteries early outcome of the Benestent-II pilot study","volume":"93","author":"Serruys","year":"1996","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.iccl.2015.12.007_bib31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A\u00a0randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2015.12.007_bib32","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A\u00a0clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iccl.2015.12.007_bib33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.iccl.2015.12.007_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc3001.093435","article-title":"Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population","volume":"104","author":"Taniuchi","year":"2001","journal-title":"Circulation"},{"issue":"9038","key":"10.1016\/j.iccl.2015.12.007_bib35","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iccl.2015.12.007_bib36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"9281","key":"10.1016\/j.iccl.2015.12.007_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.iccl.2015.12.007_bib38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.iccl.2015.12.007_bib39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.iccl.2015.12.007_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A\u00a0comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iccl.2015.12.007_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0195-668X(02)00468-2","article-title":"Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomised national multicentre trial\u2013PRAGUE-2","volume":"24","author":"Widimsky","year":"2003","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.iccl.2015.12.007_bib42","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","article-title":"Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.iccl.2015.12.007_bib43","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"issue":"9748","key":"10.1016\/j.iccl.2015.12.007_bib44","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.iccl.2015.12.007_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/hrt.2010.195438","article-title":"Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"97","author":"Siller-Matula","year":"2011","journal-title":"Heart"},{"issue":"20","key":"10.1016\/j.iccl.2015.12.007_bib46","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.iccl.2015.12.007_bib47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9711","key":"10.1016\/j.iccl.2015.12.007_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.iccl.2015.12.007_bib49","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","article-title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective randomized PLATO trial","volume":"128","author":"Steg","year":"2013","journal-title":"Circulation"},{"issue":"9122","key":"10.1016\/j.iccl.2015.12.007_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)85010-1","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade","volume":"352","author":"Topol","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.iccl.2015.12.007_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002130.pub2","article-title":"Platelet glycoprotein IIb\/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of\u00a0non-ST segment elevation acute coronary syndromes","author":"Bosch","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.1016\/j.iccl.2015.12.007_bib52","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.iccl.2015.12.007_bib53","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.iccl.2015.12.007_bib54","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.iccl.2015.12.007_bib55","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","article-title":"Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial","volume":"30","author":"Michelson","year":"2009","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.iccl.2015.12.007_bib56","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2013.01.024","article-title":"Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study","volume":"61","author":"Parodi","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2015.12.007_bib57","first-page":"e001593","article-title":"Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"8","author":"Parodi","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.iccl.2015.12.007_bib58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non\u2013ST-segment elevation acute coronary syndromes","volume":"369","author":"Montalescot","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.iccl.2015.12.007_bib59","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.iccl.2015.12.007_bib60","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2015.12.007_bib61","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.50788","article-title":"Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"308","author":"Bellemain-Appaix","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.iccl.2015.12.007_bib62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2014.08.056","article-title":"Ticagrelor crushed tablets administration in STEMI patients: The MOJITO study","volume":"65","author":"Parodi","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.iccl.2015.12.007_bib63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2015.12.007_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","article-title":"Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention","volume":"35","author":"Aradi","year":"2014","journal-title":"Eur Heart J"},{"issue":"9892","key":"10.1016\/j.iccl.2015.12.007_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.iccl.2015.12.007_bib66","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.iccl.2015.12.007_bib67","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"Trenk","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.iccl.2015.12.007_bib68","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.iccl.2015.12.007_bib69","first-page":"e001712","volume":"8","author":"Wang","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.iccl.2015.12.007_bib70","doi-asserted-by":"crossref","first-page":"E266","DOI":"10.1002\/ccd.23390","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"82","author":"Levine","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"issue":"37","key":"10.1016\/j.iccl.2015.12.007_bib71","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"issue":"9247","key":"10.1016\/j.iccl.2015.12.007_bib72","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","author":"ESPRIT Investigators","year":"2000","journal-title":"Lancet"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745815001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745815001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:59:48Z","timestamp":1718362788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745815001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2211745815001261"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2015.12.007","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet Therapy in Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}